Portfolio company
Fauna Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Basecamp Research
This company develops AI models and genomic datasets to design therapeutics for pharmaceutical and biotechnology partners.
Gero
This company develops an artificial intelligence drug discovery platform to identify therapeutic targets for chronic and age-related diseases for pharmaceutical partners.
Formation Bio
This company develops in-licensed clinical-stage drug candidates for pharmaceutical and biotechnology partners using a proprietary artificial intelligence platform to accelerate trials.
Envisagenics
This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.
Parallel Bio
This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Animol Discovery
This biopharmaceutical company develops small molecule medicines for companion and production animals using artificial intelligence and DNA-encoded library technologies.
